Clinical Trials in Michigan

Showing 9881-9900 of 16,154 trials

Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study

NCT03720639

This study will compare the reliability and timeliness in data transmission of the Abbott Confirm Rx™ loop recorder with the Medtronic Reveal LINQ™ loop recorder.

Cardiac ArrythmiasSyncopeAtrial Fibrillation+3 more

Sparrow Clinical Research Institute209 participantsStarted May 2018

Lansing, Michigan, United States • Traverse City, Michigan, United States

COMPLETEDPhase 262 miles

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02315430

This phase II trial studies how well cabozantinib-s-malate works in treating patients with ovarian, fallopian tube, or primary peritoneal cavity cancer that has come back or is growing, spreading, or getting worse. Cabozantinib-s-malate may stop the growth of tumor cells by blocking the growth of new blood vessels necessary for tumor growth and also by blocking some of the enzymes needed for cell growth.

Fallopian Tube Clear Cell AdenocarcinomaOvarian Clear Cell AdenocarcinomaRecurrent Fallopian Tube Carcinoma+2 more

National Cancer Institute (NCI)13 participantsStarted Apr 2015

Anchorage, Alaska, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +407 more locations

Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study

Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Find Trials by Condition in Michigan

A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab

Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract

Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain

Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Safety and Efficacy Study to Evaluate Denosumab Compared With Zoledronic Acid in Postmenopausal Women With Osteoporosis

Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Novel Endoluminal Clinical TreAtment of Reflux

Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )

Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis

Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease

Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men

Genetic Analysis of Hereditary Prostate Cancer

Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event